Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Lispro vs Insulin Aspart in CSII Reservoir In-use
NCT01109316Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Apr 2010; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01109316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109316.